Contents: 10 μg / 100 μg (lyophilized)
Resuspend in 10 μl / 100 μl aqua bidest.
Known applications: ELISA (less than 1 μg/ml), Western Blot (1 μg/ml), immunohistochemistry (1 μg/mI)
This antibody has not been tested for use in all applications. This does not necessarily exclude its use for non-tested procedures. The stated dilutions are recommendations only. We suggest that the applicant titrates the antibody in his/her system using appropriate negative/positive controls.
Store at: 2-8 °C (lyophilized); - 20 °C (dissolved)
Repeated thawing and freezing must be avoided
References:
1. Stocker G, Meyer HE, Wagener C and Greiling H (1991). Purification and N-terminal amino acid sequence of a chondroitin sulfate / dermatan sulfate proteoglycan isolated from intima / media preparations of human aorta. Biochem J 274: 415- 420.
2. Heintz B, Stocker G, Rentz U, Melzer H, Mrowka C, Stickeler E, Sieberth HG, Greiling H, Haubeck HD (1995). Decreased glomerular basement membrane heparan sulfate proteoglycan in essential hypertension. Hypertension 25: 399 407.
3. Stefanidis I, Heintz B, Stocker G, Mrowka C, Sieberth HG, Haubeck HD (1996). Association between heparan sulfate proteoglycan excretion and proteinuria after renal transplantation. J Am Soc Nephrol 7: 1-7.
4. Stocker G, Stickeler E, Switalla S, Fischer DC, Greiling H, Haubeck HD (1997). Development of an enzyme immuno assay specific for a core protein epitope of a novel small basement membrane associated heparan sulphate proteoglycan from human kidney. Eur J Clin Chem Clin Biochem 35: 95-99.
For research use only